| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9254197 | Journal of Hepatology | 2005 | 6 Pages |
Abstract
Treatment of acute hepatitis C with pegylated IFN-α is highly beneficial, but its effectiveness is affected by a poor rate of acceptance and/or adherence to currently available regimens, especially in IVDU and women.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Barbara Broers, Beat Helbling, Anne François, Patrick Schmid, Christian Chuard, Antoine Hadengue, Francesco Negro, for the Swiss Association for the Study of the Liver (SASL 18) for the Swiss Association for the Study of the Liver (SASL 18),